X
Edition:
United States

  • Business
    • Business Home
    • Legal
    • Deals
    • Aerospace & Defense
    • Finance
    • Autos
    • Reuters Summits
    • ADventures
    • Data Dive
  • Markets
    • Markets Home
    • U.S. Markets
    • European Markets
    • Asian Markets
    • Global Market Data
    • Stocks
    • Bonds
    • Currencies
    • Commodities
    • Futures
    • Funds
    • Earnings
    • Dividends
  • World
    • World Home
    • U.S.
    • Special Reports
    • Reuters Investigates
    • Euro Zone
    • Middle East
    • China
    • Japan
    • Mexico
    • Brazil
    • Africa
    • Russia
    • India
  • Politics
    • Politics Home
    • Polling Explorer
    • Live: U.S. Politics
    • Supreme Court
  • Tech
    • Technology Home
    • Science
    • Top 100 Global Innovators
    • Media
    • Energy and Environment
    • Innovation
  • Commentary
    • Commentary Home
    • Podcasts
  • Breakingviews
    • Breakingviews Home
    • Breakingviews Video
  • Money
    • Money Home
    • Retirement
    • Lipper Awards
    • Analyst Research
    • Stock Screener
    • Fund Screener
  • Life
    • Health
    • Sports
    • Arts
    • Entertainment
    • Oddly Enough
  • Pictures
    • Pictures Home
    • The Wider Image
    • Photographers
    • Focus 360
  • Video
Exclusive: Two Apple medical trials shed light on how HealthKit will work
  • Africa
    América Latina
  • عربي
    Argentina
  • Brasil
    Canada
  • 中国
    Deutschland
  • España
    France
  • India
    Italia
  • 日本
    México
  • РОССИЯ
    United Kingdom
  • United States
Technology News | Mon Sep 15, 2014 | 7:56am EDT

Exclusive: Two Apple medical trials shed light on how HealthKit will work

The Apple logo is pictured at its flagship retail store in San Francisco, California January 27, 2014. REUTERS/Robert Galbraith
The Apple logo is pictured at its flagship retail store in San Francisco, California January 27, 2014. REUTERS/Robert Galbraith
By Christina Farr | SAN FRANCISCO

SAN FRANCISCO Two prominent U.S. hospitals are preparing to launch trials with diabetics and chronic disease patients using Apple Inc's (AAPL.O) HealthKit, offering a glimpse of how the iPhone maker's ambitious take on healthcare will work in practice.

HealthKit, which is still under development, is the center of a new healthcare system by Apple. Regulated medical devices, such as glucose monitors with accompanying iPhone apps, can send information to HealthKit. With a patient's consent, Apple's service gathers data from various health apps so that it can be viewed by doctors in one place.

Stanford University Hospital doctors said they are working with Apple to let physicians track blood sugar levels for children with diabetes. Duke University is developing a pilot to track blood pressure, weight and other measurements for patients with cancer or heart disease.

The goal is to improve the accuracy and speed of reporting data, which often is done by phone and fax now. Potentially doctors would be able to warn patients of an impending problem. The pilot programs will be rolled out in the coming weeks.

Apple last week mentioned the trials in a news release announcing the latest version of its operating system for phones and tablets, iOS 8, but this is the first time any details have been made public. Apple declined to comment for this article.

Apple aims eventually to work with health care providers across the United States, including hospitals which are experimenting with using technology to improve preventative care to lower healthcare cost and make patients healthier.

Reuters previously reported that Apple is in talks with other U.S. hospitals. Stanford Children's Chief Medical Information Officer Christopher Longhurst told Reuters that Stanford and Duke were among the furthest along.

Longhurst said that in the first Stanford trial, young patients with Type 1 diabetes will be sent home with an iPod touch to monitor blood sugar levels between doctor's visits.

HealthKit makes a critical link between measuring devices, including those used at home by patients, and medical information services relied on by doctors, such as Epic Systems Corp, a partner already announced by Apple.

Medical device makers are taking part in the Stanford and Duke trials.

DexCom Inc (DXCM.O), which makes blood sugar monitoring equipment, is in talks with Apple, Stanford, and the U.S. Food and Drug Administration about integrating with HealthKit, said company Chief Technical Officer Jorge Valdes.

DexCom's device measures glucose levels through a tiny sensor inserted under the skin of the abdomen. That data is transmitted every five minutes to a hand-held receiver, which works with a blood glucose meter. The glucose measuring system then sends the information to DexCom's mobile app, on an iPhone, for instance.

Under the new system, HealthKit can scoop up the data from DexCom, as well as other app and device makers.

Data can be uploaded from HealthKit into Epic's "MyChart" application, where it can be viewed by clinicians in Epic's electronic health record.

PRIVACY MATTERS

While HealthKit promises to enhance the process of data-sharing between physicians and those under their care, observers have noted the potential for sensitive data to be abused. Others are leery of having all their private information stored in one location, susceptible to hackers for instance.

To ensure patient privacy, Apple is considering creating a "HealthKit Certification" for third party developers, with conditions stipulating how data must be stored securely on devices and forbidding sale of data to advertisers, according to people familiar with Apple's plans. Apple recently updated its developer guidelines with data sharing rules for health apps.

Stanford's Longhurst said he expects the pilot to be expanded quickly if there are no problems.

Rajiv Kumar, the physician leading Stanford's pilot and a pediatric endocrinologist at Stanford Children's Health, said his team may soon be able to set up alerts, so they can notify patients via Epic MyChart when their blood sugar spikes or falls.

Kumar said two young patients with diabetes have been chosen to participate in the initial trial and he hopes to extend the pilot to teens and infants.

Duke University's Ricky Bloomfield, an internal medicine pediatrician and director of mobile strategy, hopes the pilot will help doctors access the data they need to better monitor sick patients living at home.

"This could eliminate the hassle of getting data from patients, who want to give it to us," said Bloomfield. "HealthKit removes some of the error from patients' manually entering their data."

(Editing by Edwin Chan and Peter Henderson)

Our Standards: The Thomson Reuters Trust Principles

Next In Technology News

Apple sets up China data center to meet new cyber-security rules

BEIJING Apple Inc on Wednesday said it is setting up its first data center in China, in partnership with a local internet services company, to comply with tougher cyber-security laws introduced last month.

Spotify signs Sony royalty deal while Warner holds out: reports

Spotify has reached a licensing deal with a second major label, Sony Music Entertainment, according to media reports, setting the stage for a U.S. stock market listing by the music streaming leader.

MORE FROM REUTERS

Sponsored Content

From Around the WebPromoted by Revcontent

Trending Stories

    Pictures

    Photos of the day

    Sponsored Topics

    X
    Follow Reuters:
    • Follow Us On Twitter
    • Follow Us On Facebook
    • Follow Us On RSS
    • Follow Us On Instagram
    • Follow Us On YouTube
    • Follow Us On LinkedIn
    Subscribe: Feeds | Newsletters | Podcasts | Apps
    Reuters Plus | Reuters News Agency | Brand Attribution Guidelines | Careers

    Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

    Eikon
    Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface
    Elektron
    Everything you need to empower your workflow and enhance your enterprise data management
    World-Check
    Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks
    Westlaw
    Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology
    ONESOURCE
    The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
    CHECKPOINT
    The industry leader for online information for tax, accounting and finance professionals

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    • Site Feedback
    • Corrections
    • Advertising Guidelines
    • Cookies
    • Terms of Use
    • Privacy Policy